Beijing Health (Holdings) Limited provided earnings guidance for the year ended 31 December 2021. For the year, the company expects that loss attributable to the owners of the Company will decrease by approximately 75% as compared with the corresponding period in 2020. The principal reasons for the decrease in loss are as follows: Business volume of the Group has gradually recovered to the pre-pandemic level with an increase in sales revenue by approximately HKD 54 million year-on-year and the increase in gross profit by approximately HKD 14 million year-on-year; For the corresponding period of previous year, a loss of approximately HKD 36.77 million on disposal of real estate in Changping, Beijing was recorded, and the loss on disposal of assets in similar nature was absent for the current year; For the corresponding period of previous year, a provision for impairment of approximately HKD 33.5 million was made for other receivables, and a net provision for impairment of assets in similar nature of approximately HKD 9 million was recorded for the current year; As stated in the announcement published by the Group on 5 March 2021 regarding the Supplemental Agreement to Equity Transfer Agreement in relation to Beijing Beijian Inland Port International Logistics Co.

Ltd., the Group made a provision for consideration reduction of approximately HKD 21 million for the previous year, and the provision of loss in similar nature was absent for the current year; and Due to the improvement in the operating performance of the Group's associates and joint ventures, the share of loss of the associates and joint ventures for the current year decreased by approximately HKD 32 million. In addition, a provision for impairment on the investments in associates and joint ventures totaling approximately HKD 28 million was made for the corresponding period of previous year, and the provision for impairment of assets in similar nature was absent for the current year.